AMGEN INC: Human Genome Appeal to Junked Suit for Review Pending

Subscribe
TOPICS: Biotechnology | Drugs/Pharmaceuticals | Legal Issues, Litigation | Patents, Intellectual Prop. | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: California | Delaware | United States